Quick answers
- What is Nivestym?
- Nivestym is a brand name of Filgrastim, a prescription medicine. The FDA NDC Directory lists 4 Nivestym products in 4 strengths and forms.
- Who makes Nivestym?
- Hospira Inc holds the FDA application for Nivestym (BLA761080, approved July 20, 2018).
- Is there a generic or store brand of Nivestym?
- Yes. The FDA NDC Directory lists 16 other products with the same active ingredients, strength and form as a Nivestym product. Ask your pharmacist whether one is right for you.
- Has Nivestym been recalled?
- No recall linked to Nivestym products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Nivestym is
Each Nivestym product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Filgrastim · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| filgrastim 300 ug/0.5 mL injection, solution (subcutaneous) | Nivestym | 5 products, 5 companies | DailyMed |
| filgrastim 300 ug/mL injection, solution (intravenous, subcutaneous) | Nivestym | 3 products, 3 companies | DailyMed |
| filgrastim 480 ug/0.8 mL injection, solution (subcutaneous) | Nivestym | 5 products, 5 companies | DailyMed |
| filgrastim 480 ug/1.6 mL injection, solution (intravenous, subcutaneous) | Nivestym | 3 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Filgrastim →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761080 | Hospira Inc | July 20, 2018 | 4 |
Companies that list Nivestym
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Nivestym products.
- Pfizer Laboratories Div Pfizer Inc4 products
Recalls
No recall linked to Nivestym products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.